F552 in Maine. Pick another state for the same tag.
Against expectation — 2023
Maine cites F552 more often than its own record predicts
Versus expected share3.16×
3.16 times the share F552 takes of citations nationally.
Share of Maine citations0.95%
Of every deficiency written in Maine in 2023, this is the portion that was F552.
Maine0.95%
National0.30%
Share of all citations that were F552.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Maine surveyors wrote
F552 findings written in Maine, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
E · No harm, potential for more than minimal, patternJuly 1, 2026
Based on record review and interviews, the facility failed to inform a Resident and or the Resident Representative, in advance, of treatment risks and benefits, options, and alternatives related to use of psychotropic medications (prescription drugs that alter brain chemistry, affecting mood, perception, thoughts, or behavior) for 2 of 5 sampled residents reviewed (Resident #11 (R11), R7, and R27).
Findings:
1. On 7/1/26 at 9:14 a.m., R11's clinical record was reviewed, his/her signed physician orders indicate that on 2/26/26, R11 had an order for Seroquel 25 mg 1 tablet once a day (2 p.m.) and 2 tablets at bedtime (HS). …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction